Pre-made Teropavimab benchmark antibody ( Whole mAb, anti-HIV-1 gp120 CD4bs therapeutic antibody) for drug discovery and mechanism of action (MOA) research
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-Made Teropavimab biosimilar, Whole Mab: Anti-HIV-1 gp120 CD4bs therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
| Products Name (INN Index) | Pre-Made Teropavimab biosimilar, Whole Mab: Anti-HIV-1 gp120 CD4bs therapeutic antibody |
|---|---|
| INN Name | Teropavimab |
| Target | HIV-1 gp120 CD4bs |
| Format | Whole mAb |
| Derivation | Humanized |
| Species Reactivity | Human |
| CH1 Isotype | G1 |
| VD LC | Kappa |
| Highest_Clin_Trial (Jan '20) | Phase-II |
| Est. Status | Active |
| 100% SI Structure | None |
| 99% SI Structure | 4lsv:HL/4jpv:HL/5v8l:HL:GK:IM:GN/5v8m:HL:RT:SU/7ly9:HL:AM:EI:BC |
| 95-98% SI Structure | None |
| Year Proposed | 2021 |
| Year Recommended | NA |
| Companies | Gilead |
| Conditions Approved | NA |
| Conditions Active | HIV-1 |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | HIV-1 gp120 CD4bs |
| Package |
